Detalles de la búsqueda
1.
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
N Engl J Med
; 390(20): 1849-1861, 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739079
2.
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Curr Heart Fail Rep
; 21(1): 1-4, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38133864
3.
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Eur Heart J
; 44(31): 2966-2977, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210742
4.
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
JAMA
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38809561
5.
A review of current key guidelines for managing high-risk patients with diabetes and heart failure and future prospects.
Diabetes Obes Metab
; 25 Suppl 3: 33-47, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041663
6.
Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Curr Heart Fail Rep
; 20(6): 504-518, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875744
7.
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Circulation
; 144(3): 199-209, 2021 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33983794
8.
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation
; 143(6): 516-525, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186500
9.
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials.
Arterioscler Thromb Vasc Biol
; 40(3): 506-522, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31996025
10.
Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients.
MAGMA
; 33(1): 103-112, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823275
11.
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
Curr Atheroscler Rep
; 21(10): 41, 2019 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350612
12.
Correction to: Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Curr Heart Fail Rep
; 21(1): 61, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38038881
13.
Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation
; 146(4): 364-367, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877829
14.
Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
JAMA
; 329(14): 1155-1156, 2023 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039803
15.
Response by Lee et al to Letter Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)".
Circulation
; 144(3): e40, 2021 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279995
16.
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
Cardiovasc Drugs Ther
; 31(5-6): 545-549, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28948430
17.
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial.
Eur Heart J
; 36(2): 100-11, 2015 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25179764
18.
Advances in Multi-Modality Imaging in Hypertrophic Cardiomyopathy.
J Clin Med
; 13(3)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38337535
19.
Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Eur Heart J Cardiovasc Pharmacother
; 10(1): 68-80, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740450
20.
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial.
Eur J Heart Fail
; 26(4): 900-909, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558521